Login / Signup

Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis.

Eugenio MercuriAndrés Nascimento OsorioFrancesco MuntoniFilippo BuccellaIsabelle DesguerreJanbernd KirschnerMár TuliniusMaria Bernadete Dutra de ResendeLauren P MorgenrothHeather Gordish-DressmanShelley JohnsonAllan KristensenChristian WernerPanayiota TrifillisErik K HenricsonCraig M McDonaldnull null
Published in: Journal of neurology (2023)
Keyphrases
  • muscular dystrophy
  • randomized controlled trial
  • systematic review
  • duchenne muscular dystrophy
  • data analysis